Elekta AB (publ)

Elekta AB (publ) is a Swedish public limited liability company specializing in the development and production of precision radiation therapy and radiosurgery equipment for treating cancer and brain disorders. Founded in 1972 by Lars Leksell and his son Laurent Leksell to commercialize innovations like the Leksell Stereotactic System and Gamma Knife, the company has grown into a global leader with operations in over 120 countries, more than 40 offices, and approximately 4,700 employees. Its product portfolio includes advanced neurosurgery tools such as the Leksell Gamma Knife for targeted brain tumor treatment, linear accelerators like Versa HD, Elekta Unity MR-Linac, Harmony, and Evo CT-Linac for external beam radiotherapy, and brachytherapy devices including Flexitron afterloaders acquired through Nucletron. Elekta also offers software solutions like MOSAIQ oncology information system and Monaco treatment planning system to streamline clinical workflows. Headquartered in Stockholm, the company emphasizes sustainability through initiatives like the Elekta Foundation, which enhances cancer care access in low- and middle-income countries, and sustainability-linked bonds. With thousands of patents, Elekta plays a pivotal role in advancing personalized radiation medicine, improving patient outcomes worldwide.